Document is current
Any future updates will be listed below
-
Authors
Rodríguez-Arbolí, E. https://orcid.org/0000-0002-2237-6733
Phillips, G. L.
Pardee, T. S. https://orcid.org/0000-0002-1186-6948
Lazarus, H. M. https://orcid.org/0000-0002-1159-5607
Gale, R. P.
- License Information
-
More Information
Article History
Received: 8 February 2025
Revised: 11 February 2025
Accepted: 28 February 2025
First Online: 12 March 2025
Competing interests
: ER-A was a consultant to Astellas, Laboratoires Delbert, Kura Oncology and Servier, and received travel grants and/or speaker fees from Jazz, Astellas, AbbVie, Gilead and Eurocept. HML is a promotional speaker for Geron; Pfizer; Jazz Pharmaceuticals; and Seattle Genetics; a consultant to Actinium Pharmaceuticals, Inc; Pluristem Therapeutics Inc; CSL Behring; GlycoMimetics; a consultant with stock options for Partner Therapeutics; and member of the Data Safety Monitoring Board for Bristol-Myers Squibb; and BioSight. RPG is a consultant to Antengene Biotech LLC; Consultant Shenzen TargetRx; Medical Director, FFF Enterprises Inc; A speaker for Janssen Pharma, BeiGene and Hengrui Pharma; Board of Directors: Russian Foundation for Cancer Research Support and Scientific Advisory Board, StemRad Ltd. TSP has been an Advisory Board Member for AbbVie, Genentech, and Karyopharm; research support from Karyopharm and Delta Fly Pharmaceuticals.
